shutterstock_1524542537_michael_vi

Michael Vi / Shutterstock.com

9 February 2021AmericasRory O'Neill

J&J reaches $6m settlement over counterfeit surgical tools

Johnson & Johnson (J&J) has settled its case against Advanced Inventory Management (AIM), trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

4 January 2017 The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

article

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

24 January 2023 New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.

More on this story

article

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

24 January 2023 New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

4 January 2017 The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

More on this story

article

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

24 January 2023 New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

4 January 2017 The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool

USPTO clarifies AI's role in patent eligibility